Key Insights

Highlights

Success Rate

86% trial completion

Published Results

28 trials with published results (29%)

Research Maturity

60 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

10.5%

10 terminated out of 95 trials

Success Rate

85.7%

-0.9% vs benchmark

Late-Stage Pipeline

38%

36 trials in Phase 3/4

Results Transparency

47%

28 of 60 completed with results

Key Signals

28 with results86% success

Data Visualizations

Phase Distribution

74Total
Not Applicable (18)
P 1 (4)
P 2 (16)
P 3 (18)
P 4 (18)

Trial Status

Completed60
Recruiting11
Terminated10
Unknown4
Active Not Recruiting4
Not Yet Recruiting3

Trial Success Rate

85.7%

Benchmark: 86.6%

Based on 60 completed trials

Clinical Trials (95)

Showing 20 of 20 trials
NCT07494266Not ApplicableRecruitingPrimary

Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study

NCT05766839Phase 2RecruitingPrimary

Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels

NCT05090865Not ApplicableCompleted

Dietary Potassium Liberalization in Pre-Dialysis Patients

NCT07370194RecruitingPrimary

Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

NCT06884267Not ApplicableActive Not RecruitingPrimary

Hyperkalemia Quality Improvement Program (HK-QIP) Study

NCT07772856Not ApplicableNot Yet Recruiting

Liberalizing Potassium Restrictions in Patients Receiving Hemodialysis

NCT03253172Not ApplicableActive Not Recruiting

Potassium Supplementation in CKD

NCT04012138Phase 4CompletedPrimary

Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

NCT07523867Phase 4Not Yet Recruiting

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

NCT06724991Not ApplicableEnrolling By InvitationPrimary

Lower vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency Department

NCT05004363Phase 3Completed

Lokelma for RAAS Maximisation in CKD & Heart Failure.

NCT05136664Phase 3CompletedPrimary

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

NCT07054905CompletedPrimary

Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG

NCT06366230Phase 1Recruiting

Adding Urea to the Final Dialysis Fluid

NCT05056727Phase 3Terminated

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

NCT04510792WithdrawnPrimary

IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors

NCT06036823Phase 4CompletedPrimary

5 Versus 10 Units of Insulin in Hyperkalemia Management

NCT06256991Phase 4Recruiting

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

NCT07277530Not ApplicableCompleted

Nurse-Led Nutritional Education for Moroccan Dialysis Patients

NCT07251309Phase 3RecruitingPrimary

A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia

Scroll to load more

Research Network

Activity Timeline